Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Dutcher, JP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 94 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vonderheide, RH; Dutcher, JP; Anderson, JE; Eckhardt, SG; Caron, DA; Gribben, JG
      Cd40 ligand therapy of lymphoma patients - Reply

      JOURNAL OF CLINICAL ONCOLOGY
    2. Vonderheide, RH; Dutcher, JP; Anderson, JE; Eckhardt, SG; Stephans, KF; Razvillas, B; Garl, S; Butine, MD; Perry, VP; Armitage, RJ; Ghalie, R; Caron, DA; Gribben, JG
      Phase I study of recombinant human CD40 ligand in cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    3. Dutcher, JP
      Intravenous allopurinol in the prevention and treatment of tumor lysis syndrome - Introduction

      SEMINARS IN ONCOLOGY
    4. Unnikrishnan, D; Dutcher, JP; Varshneya, N; Lucariello, R; Wiernik, PH; Chiaramida, S
      Response: Monitoring of cardiac toxicity with arsenic trioxide

      BLOOD
    5. Unnikrishnan, D; Dutcher, JP; Varshneya, N; Lucariello, R; Api, M; Garl, S; Wiernik, PH; Chiaramida, S
      Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide

      BLOOD
    6. Dutcher, JP; Logan, T; Gordon, M; Sosman, J; Weiss, G; Margolin, K; Plasse, T; Mier, J; Lotze, M; Clark, J; Atkins, M
      Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: A Cytokine Working Group study

      CLINICAL CANCER RESEARCH
    7. Dutcher, JP; Novik, Y; O'Boyle, K; Marcoullis, G; Secco, C; Wiernik, PH
      20th-century advances in drug therapy in oncology - Part I

      JOURNAL OF CLINICAL PHARMACOLOGY
    8. Dutcher, JP; Novik, Y; O'Boyle, K; Marcoullis, G; Secco, C; Wiernik, PH
      20th-century advances in drug therapy in oncology - Part II

      JOURNAL OF CLINICAL PHARMACOLOGY
    9. Novik, Y; Ryan, LM; Haller, DG; Asbury, R; Dutcher, JP; Schutt, A
      Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282

      MEDICAL ONCOLOGY
    10. Deshpande, H; Dutcher, JP; Novik, Y; Oleksowicz, L
      Successful treatment of a patient on adrenal steroid replacement therapy high-dose bolus interleukin-2 for metastatic renal cell carcinoma

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    11. Atkins, MB; Lotze, MT; Dutcher, JP; Fisher, RI; Weiss, G; Margolin, K; Abrams, J; Sznol, M; Parkinson, D; Hawkins, M; Paradise, C; Kunkel, L; Rosenberg, SA
      High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993

      JOURNAL OF CLINICAL ONCOLOGY
    12. Oleksowicz, L; Dutcher, JP
      A phase II trial of dose-intensive interleukin-2 in metastatic renal cell carcinoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    13. Dutcher, JP; Wiernik, PH
      Novel biologic approaches to hematologic malignancies

      DIAGNOSTIC AND THERAPEUTIC ADVANCES IN HEMATOLOGIC MALIGNANCIES
    14. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
      Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon

      MEDICAL ONCOLOGY
    15. Wu, JJ; Caliendo, G; Hu, XP; Dutcher, JP
      Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma

      MEDICAL ONCOLOGY
    16. BHAGWATI N; SENO R; DUTCHER JP; OLEKSOWICZ L
      FULMINANT METASTATIC MELANOMA COMPLICATED BY A MICROANGIOPATHIC HEMOLYTIC-ANEMIA

      Hematopathology and molecular hematology
    17. WIERNIK PH; DUTCHER JP; EINZIG AI; SPARANO J; FRANK M; FRIEDENBERG W
      MITOXANTRONE, VINBLASTINE, AND LOMUSTINE (CCNU) (MVC) - A HIGHLY-ACTIVE REGIMEN FOR ADVANCED AND POOR-PROGNOSIS HODGKINS-DISEASE

      The cancer journal from Scientific American
    18. WADLER S; ATKINS M; KARP D; NEUBERG D; HAYNES H; DUTCHER JP
      CLINICAL-TRIAL OF WEEKLY INTENSIVE THERAPY WITH 5-FLUOROURACIL ON 2 DIFFERENT SCHEDULES COMBINED WITH INTERFERON ALPHA-2A AND FILGRASTIM INPATIENTS WITH ADVANCED SOLID TUMORS - EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY P-Z991

      The cancer journal from Scientific American
    19. MROWIEC ZR; OLEKSOWICZ L; DELEONFERNANDEZ M; LALEZARI P; DUTCHER JP; PUSZKIN EG
      APYRASE, ASCORBIC-ACID AND APROTININ AMELIORATE THE STORAGE LESION INPELLETED PLATELET PREPARATIONS (VOL 72, PG 259, 1997)

      Biotechnic & histochemistry
    20. DUTCHER JP; LEE S; PAIETTA E; BENNETT JM; STEWART JA; WIERNIK PH
      PHASE-II STUDY OF CARBOPLATIN IN BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA - EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY E1992

      Leukemia
    21. MALIK U; DUTCHER JP; OLEKSOWICZ L
      ACQUIRED GLANZMANNS-THROMBASTHENIA ASSOCIATED WITH HODGKINS LYMPHOMA - A CASE-REPORT AND REVIEW OF THE LITERATURE

      Cancer
    22. WHEATLEY D; DUTCHER JP; WIERNIK PH; HUGUET F; POLIN V; REIFFERS J; SOTTO JJ; STOPPA AM; MANDELLI F; PETTI MC; HAROUSSEAU JL; MERCIER M; POLIN V; TELLIER Z; BERMAN E; STAGG M; VOGLER WR; BEZWODA WR; ALISON R; CLARKE M; EVANS V; GRAY R; GREAVES E; HALL E; HICKS C; JAMES S; PETO R; RICHARDS S; SINCLAIR D; TOOTH A; WHEATLEY K
      A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    23. WIERNIK PH; GALLAGHER RE; KIM S; PAIETTA E; DUTCHER JP
      PILOT-STUDY OF ARSENIC TRIOXIDE (ATO) IN ACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    24. MALIK UR; DUTCHER JP; CALIENDO G; LASALA P; MITNICK R; WIERNIK PH
      PHASE-II TRIAL OF MERBARONE IN PATIENTS WITH MALIGNANT BRAIN-TUMORS

      Medical oncology
    25. DUTCHER JP; FISHER RI; WEISS G; ARONSON F; MARGOLIN K; LOUIE A; MIER J; CALIENDO G; SOSMAN JA; ECKARDT JR; ERNEST M; DOROSHOW J; ATKINS M
      OUTPATIENT SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA FOR METASTATIC RENAL-CELL CANCER - 5-YEAR FOLLOW-UP OF THE CYTOKINE WORKING GROUP-STUDY

      The cancer journal from Scientific American
    26. DUTCHER JP; ATKINS M; FISHER R; WEISS G; MARGOLIN K; ARONSON F; SOSMAN J; LOTZE M; GORDON M; LOGAN T; MIER J
      INTERLEUKIN-2-BASED THERAPY FOR METASTATIC RENAL-CELL CANCER - THE CYTOKINE WORKING GROUP EXPERIENCE, 1989-1997

      The cancer journal from Scientific American
    27. SOSMAN JA; ARONSON FR; SZNOL M; ATKINS MB; DUTCHER JP; WEISS GR; ISAACS RE; MARGOLIN KA; FISHER RI; ERNEST ML; MIER J; OLEKSOWICZ L; ECKHARDT JR; LEVITT D; DOROSHOW JH
      CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY

      Clinical cancer research
    28. MROWIEC ZR; OLEKSOWICZ L; DELEONFERNANDEZ M; PUSZKIN EG; DUTCHER JP
      APYRASE, ASCORBIC-ACID AND APROTININ AMELIORATE THE STORAGE LESION INPELLETED PLATELET PREPARATIONS

      Biotechnic & histochemistry
    29. LEAF AN; NEUBERG D; SCHWARTZ EL; WADLER S; RITCH PS; DUTCHER JP; ADAMS GL
      AN ECOG PHASE-II STUDY OF AMONAFIDE IN UNRESECTABLE OR RECURRENT CARCINOMA OF THE HEAD AND NECK (PB390)

      Investigational new drugs
    30. DUTCHER JP; COLETTI D; PAIETTA E; WIERNIK PH
      A PILOT-STUDY OF ALPHA-INTERFERON AND PLICAMYCIN FOR ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA

      Leukemia research
    31. DUTCHER JP; VENKATRAJ U; MAKOWER D; WIERNIK PH
      INTERLEUKIN-4 IS A PLEOTROPIC CYTOKINE WITH EFFECTS ON B-CELL MALIGNANCIES

      Leukemia research
    32. ATKINS MB; DUTCHER JP
      RENAL-CELL CARCINOMA

      The New England journal of medicine
    33. OLEKSOWICZ L; DUTCHER JP; DELEONFERNANDEZ M; PAIETTA E; ETKIND P
      HUMAN BREAST-CARCINOMA CELLS SYNTHESIZE A PROTEIN IMMUNORELATED TO PLATELET GLYCOPROTEIN-IB-ALPHA WITH DIFFERENT FUNCTIONAL-PROPERTIES

      The Journal of laboratory and clinical medicine
    34. OLEKSOWICZ L; DUTCHER JP; DELEONFERNANDEZ M; ETKIND P
      A GPIB-ALPHA-RELATED PROTEIN IS EXPRESSED BY FRESH HUMAN BREAST-CARCINOMA TISSUE AND IS REGULATED BY A PKC-SENSITIVE MECHANISM

      Experimental cell research
    35. OBOYLE KP; WANG YX; SCHWARTZ EL; REGL DL; EINZIG A; DUTCHER JP; WIERNIK PH; HORWITZ SB
      DEVELOPMENT OF 2 RADIOIMMUNOASSAYS TO DETECT PACLITAXEL IN SERA AND IN CEREBROSPINAL, ASCITIC, AND PLEURAL FLUIDS

      Cancer
    36. LEONARD JP; SHERMAN ML; FISHER GL; BUCHANAN LJ; LARSEN G; ATKINS MB; SOSMAN JA; DUTCHER JP; VOGELZANG NJ; RYAN JL
      EFFECTS OF SINGLE-DOSE INTERLEUKIN-12 EXPOSURE ON INTERLEUKIN-12-ASSOCIATED TOXICITY AND INTERFERON-GAMMA PRODUCTION

      Blood
    37. BHAGWATI N; DUTCHER JP; FINEBERG S; OLEKSOWICZ L
      TISSUE EXPRESSION OF A PLATELET-IMMUNORELATED GPIB RECEPTOR CORRELATES WITH BREAST MALIGNANCY AND TISSUE INVASION

      Blood
    38. OLEKSOWICZ L; DUTCHER JP; DELEONFERNANDEZ M; ETKIND A
      BREAST-CARCINOMA GPIB-ALPHA-RELATED PROTEIN EXPRESSION IS REGULATED BY A PKC-SENSITIVE MECHANISM

      Blood
    39. SUH JG; OLEKSOWICZ L; DUTCHER JP
      LEUKOCYTOCLASTIC VASCULITIS ASSOCIATED WITH NIZATIDINE THERAPY

      The American journal of medicine
    40. GUCALP R; DUTCHER JP; WIERNIK PH
      OVERVIEW BY AN ONCOLOGIST - WHAT ARE THE IMAGING NEEDS OF THE ONCOLOGIST AND ONCOLOGICAL SURGEON

      Seminars in nuclear medicine
    41. MALIK UR; OLEKSOWICZ L; DUTCHER JP; RATECH H; BOROWITZ MJ; WIERNIK PH
      ATYPICAL CLONAL T-CELL PROLIFERATION IN INFECTIOUS-MONONUCLEOSIS

      Medical oncology
    42. MAKOWER D; VENKATRAJ U; DUTCHER JP; WIERNIK PH
      OCCURRENCE OF MYELOMA IN A CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENT AFTERRESPONSE TO DIFFERENTIATION THERAPY WITH INTERLEUKIN-4

      Leukemia & lymphoma
    43. OLEKSOWICZ L; PUSZKIN E; MROWIEC Z; ISAACS R; DUTCHER JP
      ALTERATIONS IN PLATELET-FUNCTION IN PATIENTS RECEIVING INTERLEUKIN-6 AS CYTOKINE THERAPY

      Cancer investigation
    44. SPARANO JA; WIERNIK PH; HU XP; SARTA C; SCHWARTZ EL; SOEIRO R; HENRY DH; MASON B; RATECH H; DUTCHER JP
      PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    45. WIERNIK PH; DUTCHER JP
      SHOULD MAINTENANCE THERAPY (MT) FOR ACUTE MYELOID-LEUKEMIA (AML) BE REVISITED

      Experimental hematology
    46. SPARANO JA; LIPSITZ S; WADLER S; HANSEN R; BUSHUNOW PW; KIRKWOOD J; FLYNN PJ; DUTCHER JP; BENSON AB
      PHASE-II TRIAL OF PROLONGED CONTINUOUS-INFUSION OF 5-FLUOROURACIL ANDINTERFERON-ALPHA IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - EASTERN-COOPERATIVE-ONCOLOGY-GROUP PROTOCOL-3292

      American journal of clinical oncology
    47. MROWIEC ZR; OLEKSOWICZ L; ZUCKERMAN D; DELEONFERNANDEZ M; KHORSHIDI M; DUTCHER JP; PUSZKIN EG
      BUFFY COAT PLATELETS STORED IN APYRASE, APROTININ, AND ASCORBIC-ACID IN A SUSPENDED BAG - COMBINED STRATEGIES FOR REDUCING PLATELET ACTIVATION DURING STORAGE

      Transfusion
    48. WIERNIK PH; DEBELLIS R; MUXI P; DUTCHER JP
      EXTRAMEDULLARY ACUTE PROMYELOCYTIC LEUKEMIA

      Cancer
    49. OLEKSOWICZ L; DUTCHER JP; DELEON M; ETKIND P
      PLATELET IMMUNORELATED GPIB-ALPHA IS EXPRESSED BY FRESH HUMAN TUMOR SPECIMENS

      Blood
    50. OLEKSOWICZ L; DUTCHER JP
      ADHESIVE RECEPTORS EXPRESSED BY TUMOR-CELLS AND PLATELETS - NOVEL TARGETS FOR THERAPEUTIC ANTIMETASTATIC STRATEGIES

      Medical oncology
    51. PAIETTA E; NELSON DL; ANDERSEN J; DUTCHER JP; WIERNIK PH
      LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTORS ARE PREDICTIVE OF RESPONSE IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS

      Medical oncology
    52. MROWIEC ZR; OLEKSOWICZ L; DUTCHER JP; DELEONFERNANDEZ M; LALEZARI P; PUSZKIN EG
      A NOVEL TECHNIQUE FOR PREPARING IMPROVED BUFFY COAT PLATELET CONCENTRATES

      Blood cells, molecules, & diseases
    53. OBOYLE KP; COLLETTI D; MAZUREK C; WANG Y; RAY SK; DIAMOND B; ROSENBLUM MG; EPSTEIN AL; SHOCHAT D; DUTCHER JP; WIERNIK PH; KLEIN RS
      POTENTIATION OF ANTIPROLIFERATIVE EFFECTS OF MONOCLONAL-ANTIBODY LYM-1 AND IMMUNOCONJUGATE LYM-1-GELONIN ON HUMAN BURKITTS-LYMPHOMA CELLS WITH GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR

      Journal of immunotherapy with emphasis on tumor immunology
    54. WEISS GR; MARGOLIN KA; SZNOL M; ATKINS MB; OLEKSOWICZ L; ISAACS R; SOSMAN JA; DOROSHOW JH; TREHU EG; DUTCHER JP; FISHER RI
      A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA

      Journal of immunotherapy with emphasis on tumor immunology
    55. DUTCHER JP; LEONG T; MAKARY AZ; BENNETT J; FRONTIERA M; MILLER H; WIERNIK PH
      A PHASE-II STUDY OF MENOGARIL (7R-O-METHYLNOGAROL) IN PATIENTS WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP/

      Leukemia
    56. EINZIG AI; DUTCHER JP; WIERNIK PH
      LIFE-THREATENING HYPERLEUKOCYTOSIS AND PULMONARY COMPROMISE AFTER PRIMING WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN A PATIENT WITH ACUTE MYELOMONOCYTIC LEUKEMIA

      Journal of clinical oncology
    57. OLEKSOWICZ L; MROWIEC Z; ISAACS R; DUTCHER JP; PUSZKIN E
      MORPHOLOGIC AND ULTRASTRUCTURAL EVIDENCE FOR INTERLEUKIN-6 INDUCED PLATELET ACTIVATION

      American journal of hematology
    58. KHALIL A; CIOBANU N; SPARANO JA; GUCALP R; DUTCHER JP; WIERNIK PH
      PILOT-STUDY OF HIGH-DOSE MITOXANTRONE AND BUSULFAN PLUS AUTOLOGOUS BONE TRANSPLANTATION IN PATIENTS WITH ADVANCED MALIGNANCIES

      Bone marrow transplantation
    59. OLEKSOWICZ L; MROWIEC Z; SCHWARTZ E; KHORSHIDI M; DUTCHER JP; PUSZKIN E
      CHARACTERIZATION OF TUMOR-INDUCED PLATELET-AGGREGATION - THE ROLE OF IMMUNORELATED GPIB AND GPIIB IIIA EXPRESSION BY MCF7 BREAST-CANCER CELLS/

      Thrombosis research
    60. MROWIEC ZR; OLEKSOWICZ L; ZUCKERMAN D; DELEONFERNANDEZ M; KHORSHIDI M; DUTCHER JP; PUSZKIN EG
      BUFFY COAT PLATELETS STORED IN PLASMA CONTAINING APYRASE, APROTININ AND ASCORBIC-ACID

      Transfusion
    61. BENNETT RT; LERNER SE; TAUB HC; DUTCHER JP; FLEISCHMANN J
      CYTOREDUCTIVE SURGERY FOR STAGE-IV RENAL-CELL CARCINOMA

      The Journal of urology
    62. OLEKSOWICZ L; DUTCHER JP; DELEON M; ETKIND P
      GPIB-ALPHA IS EXPRESSED BY MCF-7 HUMAN BREAST-CARCINOMA CELLS

      Blood
    63. NOVIK Y; DUTCHER JP; OLEKSOWICZ L
      INTERLEUKIN-3 AND INTERLEUKIN-11 - ABSENCE OF AN EFFECT ON IN-VITRO AGONIST-INDUCED PLATELET-AGGREGATION AND PLATELET GMP-140 EXPRESSION

      Blood
    64. DUTCHER JP; LEE S; PAIETTA E; BENNETT J; STEWART J; WIERNIK PH
      AN ECOG PHASE-II STUDY OF CARBOPLATIN IN BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA (CML-BC) (E1992)

      Blood
    65. SPARANO JA; WIERNIK PH; HU X; DUTCHER JP; SARTA C; HENRY D; MASON B
      DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)

      Blood
    66. WIERNIK PH; SKLARIN NT; DUTCHER JP; SPARANO JA; GREENWALD ES
      ADJUVANT RADIOTHERAPY FOR BREAST-CANCER AS A RISK FACTOR FOR THE DEVELOPMENT OF LUNG-CANCER

      Medical oncology
    67. GUCALP R; SPARANO J; DUTCHER JP; WIERNIK PH
      INTRODUCTION TO BONE-MARROW TRANSPLANT SYMPOSIUM HELD AT THE ALBERT-EINSTEIN-CANCER-CENTER AT BRONX, NY, USA, MARCH 23 TO 25, 1994

      Medical oncology
    68. OLEKSOWICZ L; SPARANO J; OBOYLE K; VENKATRAJ U; WIERNIK PH; DUTCHER JP
      INTERLEUKINS IN CANCER-THERAPY - RATIONALE AND CURRENT STATUS

      CLINICAL IMMUNOTHERAPEUTICS
    69. SPARANO JA; FISHER RI; WEISS GR; MARGOLIN K; ARONSON FR; HAWKINS MJ; ATKINS MB; DUTCHER JP; GAYNOR ER; BOLDT DH; DOROSHOW JH; ERNEST ML; SZNOL M; MIER JW
      PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS

      Journal of immunotherapy with emphasis on tumor immunology
    70. VLOCK DR; SNYDERMAN CH; JOHNSON JT; MYERS EN; EIBLING DE; RUBIN JS; KIRKWOOD JM; DUTCHER JP; ADAMS GL
      PHASE IB TRIAL OF THE EFFECT OF PERITUMORAL AND INTRANODAL INJECTIONSOF INTERLEUKIN-2 IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OFTHE HEAD AND NECK - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL

      Journal of immunotherapy with emphasis on tumor immunology
    71. MARGOLIN K; ARONSON FR; SZNOL M; ATKINS MB; GUCALP R; FISHER RI; SUNDERLAND M; DOROSHOW JH; ERNEST ML; MIER JW; DUTCHER JP; GAYNOR ER; WEISS GR
      PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA

      Journal of immunotherapy with emphasis on tumor immunology
    72. HAWKINS MJ; ATKINS MB; DUTCHER JP; FISHER RI; WEISS GR; MARGOLIN KA; RAYNER AA; SZNOL M; PARKINSON DR; PAIETTA E; GAYNOR ER; BOLDT DH; DOROSHOW JH; ARONSON FR
      A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA

      Journal of immunotherapy with emphasis on tumor immunology
    73. WIERNIK PH; DUTCHER JP; LEAF AN; LIAO ZH; PAIETTA E; ROSENSTREICH DL
      OBJECTIVE RESPONSE OF MULTIPLE-MYELOMA TO CYCLOSPORINE-A

      Leukemia & lymphoma
    74. DUTCHER JP; BENCHABBAT A; JONES JG; WIERNIK PH
      UNIQUE DERMATOLOGICAL COMPLICATION OF RHM-CSF TREATMENT

      Leukemia & lymphoma
    75. DUTCHER JP; BENCHABBAT A; JONES JG; WIERNIK PH
      UNIQUE DERMATOLOGICAL COMPLICATION OF RHM-CSF TREATMENT

      Leukemia & lymphoma
    76. SPARANO JA; WIERNIK PH; STRACK M; LEAF A; BECKER NH; SARTA C; CARNEY D; ELKIND R; SHAH M; VALENTINE ES; DUTCHER JP
      INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE IN HIV-RELATEDNON-HODGKINS-LYMPHOMA - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN

      Leukemia & lymphoma
    77. MERER DM; DUTCHER JP; MERCANDO A; BRODMAN R; SUHRLAND MJ; BHANDARI A; ZIMMERMAN D; MITCHELL MS; WIERNIK PH
      CASE-REPORT - CLINICAL FINDINGS AND SUCCESSFUL RESECTION OF MELANOMA METASTATIC TO THE RIGHT ATRIUM

      Cancer investigation
    78. WIERNIK PH; DUTCHER JP; TODD M; CALIENDO G; BENSON L
      POLYETHYLENE GLYCOLATED INTERLEUKIN-2 AS MAINTENANCE THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION

      American journal of hematology
    79. OLEKSOWICZ L; ZUCKERMAN D; MROWIEC Z; PUSZKIN E; DUTCHER JP
      EFFECTS OF INTERLEUKIN-2 ADMINISTRATION ON PLATELET-FUNCTION IN CANCER-PATIENTS

      American journal of hematology
    80. SAGAYADAN GE; WIERNIK PH; SUN N; AHEARN G; THOMPSON D; HALLAM SJ; HU XP; DUTCHER JP; GALLAGHER RE
      EFFECT OF RETINOIC ACID AND INTERFERON-ALPHA ON GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS IN CHRONIC MYELOID-LEUKEMIA - INCREASED INHIBITION BY ALL-TRANS-RETINOIC AND 13-CIS-RETINOIC ACIDS IN ADVANCED-STAGE DISEASE

      Leukemia research
    81. OLEKSOWICZ L; STRACK M; DUTCHER JP; SUSSMAN I; CALIENDO G; SPARANO J; WIERNIK PH
      A DISTINCT COAGULOPATHY ASSOCIATED WITH INTERLEUKIN-2 THERAPY

      British Journal of Haematology
    82. WALPOLE ET; DUTCHER JP; SPARANO J; GUCALP R; EINZIG A; PAIETTA E; CIOBANU N; GRIMA K; CALIENDO G; CAVASOTTO G; WIERNIK PH
      SURVIVAL AFTER PHASE-II TREATMENT OF ADVANCED RENAL-CELL CARCINOMA WITH TAXOL OR HIGH-DOSE INTERLEUKIN-2

      Journal of immunotherapy with emphasis on tumor immunology
    83. DUTCHER JP
      INTERFERONS AND INTERLEUKINS IN CANCER-THERAPY

      Cancer research, therapy & control
    84. WIERNIK PH; DUTCHER JP; PAIETTA E; GUCALP R; MARKUS S; WEINBERG V; AZAR C; GARL S; BENSON L
      LONG-TERM FOLLOW-UP OF TREATMENT AND POTENTIAL CURE OF ADULT ACUTE LYMPHOCYTIC-LEUKEMIA WITH MOAD - A NON-ANTHRACYCLINE CONTAINING REGIMEN

      Leukemia
    85. SPARANO JA; WIERNIK PH; LEAF A; DUTCHER JP
      INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN RELAPSED AND RESISTANT NON-HODGKINS-LYMPHOMA - EVIDENCE FOR A SCHEDULE-DEPENDENTEFFECT FAVORING INFUSIONAL ADMINISTRATION OF CHEMOTHERAPY

      Journal of clinical oncology
    86. SPARANO JA; FISHER RI; SUNDERLAND M; MARGOLIN K; ERNEST ML; SZNOL M; ATKINS MB; DUTCHER JP; MICETICH KC; WEISS GR; DOROSHOW JH; ARONSON FR; RUBINSTEIN LV; MIER JW
      RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA

      Journal of clinical oncology
    87. DUTCHER JP; WIERNIK PH; TODD M; CALIENDO G; BENSON L
      INTERLEUKIN-2 AS MAINTENANCE THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION

      Experimental hematology
    88. MAZUREK C; DUTCHER JP; SCHWARTZ EL; GARL S; BENSON L; WIERNIK PH
      PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MENOGARIL (7-CON-O-METHYLNOGAROL) IN PREVIOUSLY TREATED PATIENTS WITH ACUTE-LEUKEMIA

      Investigational new drugs
    89. DUTCHER JP; WIERNIK PH
      THE ROLE OF RECOMBINANT INTERLEUKIN-2 IN THERAPY FOR HEMATOLOGIC MALIGNANCIES

      Seminars in oncology
    90. SPARANO JA; WADLER S; LIEBES L; ROBERT NJ; SCHWARTZ EL; DUTCHER JP
      PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER

      Cancer research
    91. DUTCHER JP; LEONG T; MAKARY A; PAIETTA E; BENNETT J; CASSILETH P; WIERNIK PH
      PHASE-II STUDY OF MENOGARIL IN PATIENTS (PTS) WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA (AML) - EST 8490

      Blood
    92. SPARANO JA; WIERNIK PH; DUTCHER JP; LEAF A; KHALIL A
      INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) IN RELAPSED, RESISTANT, AND POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT

      Blood
    93. DUTCHER JP; WIERNIK PH; EINZIG AI; CASSILETH P
      MITOXANTRONE, VINBLASTINE AND CCNU (MVC) - A HIGHLY-ACTIVE REGIMEN INPOOR-PROGNOSIS HODGKINS-DISEASE (HD)

      Blood
    94. SPARANO JA; WIERNIK PH; DUTCHER JP; SARTA C; STRACK M; LEAF A
      INFUSIONAL CYCLOPHOSPHAMIDE-(C), DOXORUBICIN-(D), AND ETOPOSIDE-(E) IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 06:21:31